Kestra Advisory Services’s Co-Diagnostics CODX Stock Holding History
Bought
Maintained
Sold
Other funds holding CODX
PAG
SAM
SS
HWA
DB
Kestra Advisory Services's CODX Position: Q1 2026 in Review
Kestra Advisory Services sold out of Co-Diagnostics (CODX) in Q1 2026, closing a stake of 2,940 shares — an estimated $14.9K sold.
Kestra Advisory Services first reported a position in CODX in Q1 2022 and held it in 14 quarters. The position peaked at $187K in Q2 2024. 14 funds tracked by Wall St. Rank hold CODX as of Q1 2026.
- Kestra Advisory Services reported no remaining Co-Diagnostics position as of Q1 2026 after selling out during the quarter.
- Kestra Advisory Services sold 2,940 Co-Diagnostics shares in Q1 2026, an estimated $14.9K.
- Kestra Advisory Services first reported a position in Co-Diagnostics in Q1 2022 and held it in 14 quarters.
- Kestra Advisory Services's Co-Diagnostics position peaked at $187K in Q2 2024.
- 14 funds tracked by Wall St. Rank held Co-Diagnostics as of Q1 2026.
Based on Kestra Advisory Services's 13F filing for Q1 2026, filed 30 Apr 2026.